MENU

ALMS Alumis Inc. Forecast, Technical & Fundamental Analysis

Alumis Inc is a clinical-stage biopharmaceutical company with an initial focus on developing its two Tyrosine Kinase 2 ("TYK2") inhibitors: envudeucitinib ("envu"), an allosteric TYK2 inhibitor for the treatment of PsO and SLE; and A-005, a central nervous system ("CNS") penetrant allosteric TYK2 inhibitor, to offer the therapeutic benefit of TYK2 inhibition within the CNS for a broad range of neuroinflammatory and neurodegenerative diseases... Show more

ALMS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
ALMS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CENX35.030.83
+2.43%
Century Aluminum Company
RPC8.270.05
+0.61%
Ridgepost Capital Inc
CPRT27.870.12
+0.43%
Copart
AMBR1.70-0.11
-6.08%
Amber International Holding Limited
FMST0.50-0.03
-6.52%
Foremost Clean Energy Ltd

ALMS and Stocks

Correlation & Price change

A.I.dvisor tells us that ALMS and DRUG have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALMS and DRUG's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALMS
1D Price
Change %
ALMS100%
-3.01%
DRUG - ALMS
31%
Poorly correlated
-5.37%
MRNA - ALMS
30%
Poorly correlated
-7.82%
ZNTL - ALMS
28%
Poorly correlated
-4.91%
ARVN - ALMS
28%
Poorly correlated
-2.65%
VKTX - ALMS
27%
Poorly correlated
-8.04%
More
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
280 East Grand Avenue
Phone
+1 650 231-6625
Employees
224
Web
https://www.alumis.com
Alumis (ALMS) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com